<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04282473</url>
  </required_header>
  <id_info>
    <org_study_id>NIMAO/2018-02/MP-01</org_study_id>
    <nct_id>NCT04282473</nct_id>
  </id_info>
  <brief_title>Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh</brief_title>
  <acronym>RESEDAE</acronym>
  <official_title>Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh: Material-epidemiology Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a follow-up of the GRECCAR 07 cohort (NCT01380860). Patients will be evaluated
      5 years following terminal colostomy to observe patient long-term patient outcomes from
      colostomy with and without mesh placement.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of parastomal hernia between groups</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Percentage patients with parastomal hernia taken from patient medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Date of parastomal hernia</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Date of parastomal hernia taken from patient records</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Protrusion around the stoma</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported pain</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occlusion</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incarceration</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported quality of life</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Stoma-QoL questionnaire - a 20-item questionnaire on a four-point Likert scale with total score ranging from 0 (worst score) to 100 (best score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at colostomy site</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>0-100 scale (no pain to intolerable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>0-100 scale (very uncomfortable to very comfortable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported satisfaction</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>0-100 scale (not at all satisfied to very satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of specialist and general consultations attended by patients between groups</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>number of consultations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of medications taken in each group</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Number of medications taken</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other associated treatment received by patients in each group</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>number of treatments received</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehabilitation sessions undergone by patients in each group</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>number of rehabilitation sessions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sick leave taken by patients in each group</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of patients care</measure>
    <time_frame>5 years after colostomy formation</time_frame>
    <description>Euros</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">134</enrollment>
  <condition>Colostomy Stoma</condition>
  <condition>Parastomal Hernia</condition>
  <arm_group>
    <arm_group_label>with mesh</arm_group_label>
    <description>Placement of lightweight (&lt;50g/m2) monofilament mesh during colostomy formation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no mesh</arm_group_label>
    <description>colostomy without mesh placement</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of patients included in the GRECCAR 07 cohort.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must be affiliated with a health insurance programme

          -  Patient was included in the GRECCAR 07 cohort (PHRC National 2011; N° RCB:
             2011-A01572-39 - ClinicalTrials.gov ID: NCT01380860)

          -  Patient received colostomy 5 years ago

        Exclusion Criteria:

          -  The subject is participating in another category I interventional study, or is in a
             period of exclusion determined by a previous study

          -  The subject signals opposition to participating in the study

          -  The patient is under safeguard of justice or state guardianship

          -  The patient is pregnant or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Michel Prudhomme, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nimes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michel Prudhomme, MD</last_name>
    <phone>06.43.50.35.22</phone>
    <email>michel.prudhomme@chu-nimes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>L'Hôpital Jean Minjoz</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Zaher Lakkis</last_name>
      <phone>03 81 66 71 73</phone>
      <email>zlakkis@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>Zaher Lakkis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Eric Rullier</last_name>
      <phone>05 56 79 58 10</phone>
      <email>eric.rullier@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Eric Rullier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Clermont- Ferrand Hôtel -Dieu</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Denis Pezet</last_name>
      <phone>04 73 75 04 94</phone>
      <email>dpezet@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Denis Pezet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Beaujon (AP-HP)</name>
      <address>
        <city>Clichy</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Yves Panis</last_name>
      <phone>01 40 87 45 47</phone>
      <email>yves.panis@bjn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Yves Panis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Albert Michallon</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jean-Luc Faucheron</last_name>
      <phone>04 76 76 55 26</phone>
      <email>JLFaucheron@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Luc Faucheron</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Mehrdad Jafari</last_name>
      <phone>03 20 29 59 20</phone>
      <email>m-jafari@o-lambret.fr</email>
    </contact>
    <investigator>
      <last_name>Mehrdad Jafari</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon-Sud</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Eddy Cotte</last_name>
      <phone>04 78 86 18 01</phone>
      <email>eddy.cotte@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Eddy Cotte</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Régional de Lutte contre le Cancer Institut Paoli-Calmettes</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Bernard Lelong</last_name>
      <phone>04 91 22 37 00</phone>
      <email>lelongb@ipc.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Bernard Lelong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital La Timone, AP-HM</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Julie Duclos</last_name>
      <phone>04 91 38 58 52</phone>
      <email>julie.duclos@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Julie Duclos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CRLC Val d'Aurelle - Paul Lamarque</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Philippe Rouanet</last_name>
      <phone>04 67 61 31 14</phone>
      <email>philippe.rouanet@montpellier.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Rouanet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Hôtel-Dieu - CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Guillaume Meurette</last_name>
      <phone>02 40 08 30 22</phone>
      <email>guillaume.meurette@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Guillaume Meurette</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Anissa Megzari</last_name>
      <phone>04.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Michel Prudhomme</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Antoine (AP-HP)</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Yann Parc</last_name>
      <phone>01 49 28 25 47</phone>
      <email>yann.parc@sat.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Yann Parc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Bernard Meunier</last_name>
      <phone>02 99 28 42 65</phone>
      <email>bernard.meunier@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Bernard Meunier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles-Nicolle</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jean-Jacques Tuech</last_name>
      <phone>02 32 88 85 72</phone>
      <email>jean-jacques.tuech@univ-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Jacques Tuech</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Purpan - CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Guillaume Portier</last_name>
      <phone>05 61 77 25 30</phone>
      <email>portier.g@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Guillaume Portier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 21, 2020</study_first_submitted>
  <study_first_submitted_qc>February 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

